Evidence map›Paper›PMID 20012839›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2010

Multiple antigen immunostaining procedures.

Tibor Krenacs, Laszlo Krenacs, Mark Raffeld

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. 4FISH-IF, a four-color dual-gene FISH combined with p63 immunofluorescence to evaluate NKX3.1 and MYC status in prostate cancer.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2013
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Tibor Krenacs1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Laszlo Krenacs
Mark Raffeld
Bay Zoltán Foundation for Applied Research · HUNational Institutes of Health · USSemmelweis University · HU

Funding

Immunohistochemistry Core LaboratoryZICBC011087 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RAFFELD, MARK · 2009 to 2015
$7.4M
Immunohistochemistry Core LaboratoryZ01BC011087 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RAFFELD, MARK · 2008 to 2008
$406k
Intramural NIH HHS Z01 BC011087
6 · The paper itself

Abstract

Detection of multiple antigens in the same tissue section can be done by combining a range of immunohisto/cytochemical techniques based either on light microscopic chromogenic precipitates or fluorochrome labeling. Light microscopic techniques preferred for this purpose use combinations of immunogold silver staining (black precipitate), immunoperoxidase, immunoalkaline phosphatase and immunogalactosidase methods using chromogens of different colors. Fluorochrome labels favored for these combinations include AMCA (blue), FITC (green), rhodamine (orange-red) and Cy5 (far red), their matching synthetic members from the Alexa series, or quantum dots. Antibodies directly labeled or those from noncross-reacting animal species (e.g., mouse, rabbit, goat, guinea pig etc.) can be applied simultaneously. When the antigens of interest are in separate cells or cell compartments (e.g., in cell membrane, cytoplasm or nucleus), and only cross-reacting antibodies are available, there have also been ways of avoiding unwanted cross-talk. These include the exploitation of the shielding effect of chromogens; inactivation of immuno-sequences of the first staining by using either acidic elution, formaldehyde fixation or microwave heating; combining unlabeled and hapten-labeled antibodies; or using labeled monovalent F(ab) secondary antibodies. In this chapter we briefly discuss the principle of multiple antigen immunolabeling and provide useful protocols for its performance.

Indexed as

AnimalsAntibodiesAntigensCervix UteriChemical PrecipitationConnexin 43Cross ReactionsEpitheliumFemaleFluorescent Antibody TechniqueFluorescent DyesHumansImmunoenzyme TechniquesKeratin-19MicroscopyStaining and LabelingAntibodiesAntigensConnexin 43Fluorescent DyesKeratin-19

Identifiers

PMID20012839
PMCPMC7670878
OpenAlexW1483878571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.